TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

IPSEN PHARMA

OncologyNeurologyGastroenterology
Pharma

IPSEN PHARMA is a pharmaceutical company focused on Oncology, Neurology, Gastroenterology.

2007
Since
1
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

SOMATULINE DEPOT 2024-07-11
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 77%
1 drugs Phase 3: 6 Phase 2: 5 Phase 1: 10
Neurology 15%
0 drugs Phase 3: 2 Phase 2: 1
Gastroenterology 8%
0 drugs Phase 2: 1 Phase 1: 3

Pipeline Strength Pro

Loading...

Competitors Pro

Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Neurology
Takeda big-pharma
Oncology, Gastroenterology, Neurology
Pfizer big-pharma
Oncology, Gastroenterology
Amgen biotech
Oncology, Gastroenterology, Neurology
EMD SERONO INC biotech
Oncology, Neurology, Gastroenterology